跳至主要内容
临床试验/JPRN-UMIN000035766
JPRN-UMIN000035766已完成未知

Effect of the supplement on accommodation of the eye in middle- and old-aged adults: A randomized, double blinded, placebo controlled, and parallel group comparison study. - Effect of the supplement on accommodation of the eye in middle- and old-aged adults

HUMA R&D CORP0 个研究点目标入组 100 人开始时间: 2019年2月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subject who is taking medication or under medical treatment. 2. Subject who is under exercise therapy or dietetic therapy. 3. Subject who has an allergy for test food. 4. Subject who has or had a history of either medicine or alcohol dependence syndrome. 5. Subject who has or had a history of mental illness (depression) or sleep disturbance. 6. Subject who is on a night-shift or is a shift worker. 7. Subject whose lifestyle is extremely irregular. 8. Subject who has an unbalanced diet. 9. Subject who has or had a history of disease in liver, kidney, cardiovascular system, gastrointestinal, lung, blood or metabolic function. 10. Subject who has or had a history of eye disease (Not include minor eye diseases). 11. Subject who can stop taking any kind of health food, supplement or medicine other than the test foods during the current study. 12. Subject who has participated in other clinical studies within the past 3 months from the day of the consent acquisition or who is planning to participate in other clinical studies during the current study. 13. Subject who has blood drawn 200mL within the past 1 months or 400mL within the past 3 months from the day of the consent acquisition. 14. Subject who is planning to get pregnant after the day of informed consent or is currently pregnant and lactating. 15. Subject who can't keep the daily records. 16. Subject who is judged as an inappropriate candidate according to the screening data. 17. Subject who is considered as an inappropriate candidate by the doctor in charge.

研究者

发起方
HUMA R&D CORP

相似试验